EUVIMEDEUVIMED entdecken
Open Access

Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation

Miao-Miao Kong iD, Tao Wei, Bo Liu, Zi-Xuan Xi, Jun-Tao Ding, Xin Liu, Ke Li, Tian-Li Qin, Zhen-Yong Qian, Wen-Can Wu, Jian-Zhang Wu, Wu-Lan Li iD

Future Medicinal Chemistry · 2024

DOI: 10.1080/17568919.2024.2385288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Miao-Miao Kong und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Machine Learning, Protein Kinase Inhibitors, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: Build a virtual screening model for ULK1 inhibitors based on artificial intelligence.Materials & methods: Build machine learning and deep learning classification models and combine molecular docking and biological evaluation to screen ULK1 inhibitors from 13 million compounds. And molecular dynamics was used to explore the binding mechanism of active compounds.Results & conclusion: Possibly due to less available training data, machine learning models significantly outperform deep learning models. Among them, the Naive Bayes model has the best performance. Through virtual screening, we obtained three inhibitors with IC50 of μM level and they all bind well to ULK1. This study provides an efficient virtual screening model and three promising compounds for the study of ULK1 inhibitors. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autophagy-Related Protein-1 HomologMachine LearningProtein Kinase InhibitorsMolecular Docking SimulationDrug DiscoveryHumansIntracellular Signaling Peptides and ProteinsDrug Evaluation, PreclinicalMolecular Dynamics SimulationMolecular Structure

Stichwörter der Autor:innen

ULK1 inhibitorsdrug discoverymachine learningmolecular dynamics simulationvirtual screening

Substanzen

Autophagy-Related Protein-1 HomologProtein Kinase InhibitorsULK1 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision & Brain Health), Wenzhou, Zhejiang, 325000, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
  • Faculty of Applied Sciences, Macao Polytechnic University, Macao, SAR, China.
  • The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, 325027, China.

ORCID-Profile: Miao-Miao Kong, Wu-Lan Li

Zitieren

APA

Kong, M. M., Wei, T., Liu, B., Xi, Z. X., Ding, J. T., Liu, X., Li, K., Qin, T. L., Qian, Z. Y., Wu, W. C., Wu, J. Z., & Li, W. L. (2024). Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2385288

Vancouver

Kong MM, Wei T, Liu B, Xi ZX, Ding JT, Liu X, et al. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2385288

BibTeX
@article{Kong2024,
  author = {Kong, Miao-Miao and Wei, Tao and Liu, Bo and Xi, Zi-Xuan and Ding, Jun-Tao and Liu, Xin and Li, Ke and Qin, Tian-Li and Qian, Zhen-Yong and Wu, Wen-Can and Wu, Jian-Zhang and Li, Wu-Lan},
  title = {Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.1080/17568919.2024.2385288}
}
Kostenlos starten →